BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38199863)

  • 1. Fragility of randomised controlled trials for systemic lupus erythematosus and lupus nephritis therapies.
    Figueroa-Parra G; Putman MS; Crowson CS; Duarte-García A
    Lupus Sci Med; 2024 Jan; 11(1):. PubMed ID: 38199863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragility of cardiovascular outcome trials (CVOTs) examining nutrition interventions among patients with diabetes mellitus: a systematic review of randomized controlled trials.
    Taouktsi N; Papageorgiou ST; Tousinas G; Papanikolopoulou S; Grammatikopoulou MG; Giannakoulas G; Goulis DG
    Hormones (Athens); 2022 Dec; 21(4):665-681. PubMed ID: 36129664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fragility of statistical findings in the reverse total shoulder arthroplasty literature: a systematic review of randomized controlled trials.
    Yendluri A; Chiang JJ; Linden GS; Megafu MN; Galatz LM; Parsons BO; Parisien RL
    J Shoulder Elbow Surg; 2024 Jul; 33(7):1650-1658. PubMed ID: 38281679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials.
    Steiger S; Ehreiser L; Anders J; Anders HJ
    Front Immunol; 2022; 13():999704. PubMed ID: 36211360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of randomized controlled trials on anal fistula conducted between 2000 and 2020 based on the Fragility Index and Reverse Fragility Index.
    Placer-Galán C; Enriquez-Navascués JM; Lopetegui AE; Ansorena YS
    Colorectal Dis; 2023 Aug; 25(8):1572-1577. PubMed ID: 37400967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fragility index and reverse fragility index of FDA investigational device exemption trials in spinal fusion surgery: a systematic review.
    Proal JD; Moon AS; Kwon B
    Eur Spine J; 2024 May; ():. PubMed ID: 38802596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robustness of outcomes in trials evaluating sodium-glucose co-transporter 2 inhibitors for heart failure.
    Usman MS; Khan MS; Fonarow GC; Greene SJ; Friede T; Vaduganathan M; Filippatos G; Coats AJS; Anker SD; Butler J
    ESC Heart Fail; 2022 Apr; 9(2):885-893. PubMed ID: 35029056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Statistical Fragility of Tranexamic Acid Use in the Orthopaedic Surgery Literature: A Systematic Review of Randomized Controlled Trials.
    Brown AN; Yendluri A; Lawrence KW; Cordero JK; Moucha CS; Hayden BL; Parisien RL
    J Am Acad Orthop Surg; 2024 Jun; 32(11):508-515. PubMed ID: 38574390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Robustness of the Landmark Cardiovascular Outcome Trials of Antidiabetic Drugs - A Systematic Review.
    Bose D; Konwar M
    Curr Diabetes Rev; 2022; 18(6):e140921196472. PubMed ID: 34521330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab in systemic lupus erythematosus and lupus nephritis.
    Beckwith H; Lightstone L
    Nephron Clin Pract; 2014; 128(3-4):250-4. PubMed ID: 25471633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fragility and reverse fragility indices of proximal humerus fracture randomized controlled trials: a systematic review.
    Kyriakides PW; Schultz BJ; Egol K; Leucht P
    Eur J Trauma Emerg Surg; 2022 Dec; 48(6):4545-4552. PubMed ID: 34056677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Statistical Fragility of Marrow Stimulation for Cartilage Defects of the Knee: A Systematic Review of Randomized Controlled Trials.
    Yendluri A; Alexanian A; Chari RR; Corvi JJ; Namiri NK; Song J; Alaia MJ; Li X; Parisien RL
    Cartilage; 2024 Feb; ():19476035241233441. PubMed ID: 38403983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical Outcomes Guiding Periprosthetic Joint Infection Prevention and Revision Are Fragile: A Systematic Review of Randomized Controlled Trials.
    Yendluri A; Gonzalez C; Cordero JK; Hayden BL; Moucha CS; Parisien RL
    J Arthroplasty; 2024 Jul; 39(7):1869-1875. PubMed ID: 38331358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragility of results from randomized controlled trials supporting the guidelines for the treatment of osteoporosis: a retrospective analysis.
    Huang X; Chen B; Thabane L; Adachi JD; Li G
    Osteoporos Int; 2021 Sep; 32(9):1713-1723. PubMed ID: 33595680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robustness of Longitudinal Safety and Efficacy After Paclitaxel-Based Endovascular Therapy for Treatment of Femoro-Popliteal Artery Occlusive Disease: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    D'Oria M; Mastrorilli D; Secemsky E; Behrendt CA; Veraldi G; DeMartino R; Mani K; Budtz-Lilly J; Scali S; Saab F; Calvagna C; Mezzetto L; Ruaro B; Lepidi S
    Ann Vasc Surg; 2024 Apr; 101():164-178. PubMed ID: 38154491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Statistical Fragility of Management Options for Acute Achilles Tendon Ruptures - A Systematic Review of Randomized Control Trial with Fragility Analysis.
    Doyle TR; Davey MS; Hurley ET
    J ISAKOS; 2022 Aug; 7(4):72-81. PubMed ID: 36189473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol.
    Teng YKO; Bruce IN; Diamond B; Furie RA; van Vollenhoven RF; Gordon D; Groark J; Henderson RB; Oldham M; Tak PP
    BMJ Open; 2019 Mar; 9(3):e025687. PubMed ID: 30898822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpreting the Current Literature on Outcomes of Robotic-Assisted Versus Conventional Total Knee Arthroplasty Using Fragility Analysis: A Systematic Review and Cross-Sectional Study of Randomized Controlled Trials.
    Zabat MA; Giakas AM; Hohmann AL; Lonner JH
    J Arthroplasty; 2024 Jul; 39(7):1882-1887. PubMed ID: 38309638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the Reverse Fragility Index to Statistically Nonsignificant Randomized Clinical Trial Results.
    Khan MS; Fonarow GC; Friede T; Lateef N; Khan SU; Anker SD; Harrell FE; Butler J
    JAMA Netw Open; 2020 Aug; 3(8):e2012469. PubMed ID: 32756927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fragility of Statistical Significance in Sham Orthopaedic Surgery: A Systematic Review of Randomized Controlled Trials.
    Pearsall C; Constant M; Saltzman BM; Parisien RL; Levine W; Trofa D
    J Am Acad Orthop Surg; 2023 Nov; 31(21):e994-e1002. PubMed ID: 37678845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.